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Background: Obesity and depression are both associated with changes in sleep/wake
regulation, with potential implications for individualized treatment especially in comorbid
individuals suffering from both. However, the associations between obesity, depression,
and subjective, questionnaire-based and objective, EEG-based measurements of
sleepiness used to assess disturbed sleep/wake regulation in clinical practice are not
well known.
Objectives: The study investigates associations between sleep/wake regulation
measures based on self-reported subjective questionnaires and EEG-derived
measurements of sleep/wake regulation patterns with depression and obesity and
how/whether depression and/or obesity affect associations between such self-reported
subjective questionnaires and EEG-derived measurements.
Methods: Healthy controls (HC, NHC = 66), normal-weighted depressed (DEP, NDEP =
16), non-depressed obese (OB, NOB = 68), and obese depressed patients (OBDEP,
NOBDEP = 43) were included from the OBDEP (Obesity and Depression, University Leipzig,
Germany) study. All subjects completed standardized questionnaires related to daytime
sleepiness (ESS), sleep quality and sleep duration once as well as questionnaires related
to situational sleepiness (KSS, SSS, VAS) before and after a 20 min resting state EEG in
eyes-closed condition. EEG-based measurements of objective sleepiness were extracted
by the VIGALL algorithm. Associations of subjective sleepiness with objective sleepiness
and moderating effects of obesity, depression, and additional confounders were
investigated by correlation analyses and regression analyses.
Results: Depressed and non-depressed subgroups differed significantly in most
subjective sleepiness measures, while obese and non-obese subgroups only differed
significantly in few. Objective sleepiness measures did not differ significantly between the
subgroups. Moderating effects of obesity and/or depression on the associations between
subjective and objective measures of sleepiness were rarely significant, but associations
between subjective and objective measures of sleepiness in the depressed subgroupg April 2020 | Volume 11 | Article 2001
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they did not.
Conclusion: This study provides some evidence that both depression and obesity can
affect the association between objective and subjective sleepiness. If confirmed, this
insight may have implications for individualized diagnosis and treatment approaches in
comorbid depression and obesity.Keywords: obesity, depression, EEG, sleepiness, VIGALLBACKGROUND
With over 1.9 billion adults affected worldwide (1), overweight
and obesity cause significant negative health outcomes (2).
Obesity is a well-known risk factor for somatic diseases such as
diabetes, heart attacks, cancer, or sleep apnea (3). However,
obesity also often co-occurs with mental illness, especially
affective disorders like depression, and causes an enormous
burden of disease (4) due to the deterioration in both the
quality of life and the level of social functioning it entails.
Similar physiological processes are involved in the development
and maintenance of both diseases (5). Nevertheless, associations
between obesity and depression are very complex and not equally
applicable to all people affected (6). This might be due to the fact
that depression is a heterogenous disorder with multiple aetiological
pathways interacting with genetic, neuroendocrinal, neurochemical,
and neuroimmunlogical processes (7).
To further our understanding of how depression and obesity
interact from a clinical perspective, the present paper is concerned
with the link between depression and obesity focusing on sleep/
wake regulation as a symptom complex that might connect both
diseases, specifically, the occurrence and severity of disturbed sleep
patterns. To do so, the following paragraphs provide precise
definitions of brain arousal regulation, depression, atypical
depression, and our operationalizations of these constructs before
we describe our hypotheses in more detail.
According to the Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5, 8), diagnosing a severe episode
of depression requires five or more symptoms that can affect
both the mental and physical well-being of the individual to
persist for at least two weeks.
Symptoms include depressed mood, loss of interest, joylessness,
feelings of worthlessness, and cognitive impairment, but also
describe changes in activity levels, appetite, and sleep quality.
Interestingly, the clinical manifestations of the heterogenous
cohort of depressed patients differ particularly with regard to
different characteristics of disturbances in sleep/wake regulation
and appetite.
Therefore, atypical depression (AD) was included as a separate
diagnosis in the fourth edition of Diagnostic and Statistical
Manual for Mental Disorders in 1994 (DSM-IV, 9). AD defines
a distinct symptom complex in depressed patients including
mood reactivity, increased appetite and hypersomnia (10).
In fact, it is theorized that atypical depressed patients often
suffer from significant weight gain or an increase in appetite withg 2excessive sleep all through the day, whereas non-atypical
depressed patients are characterized by significant weight loss
or decrease in appetite and decreased sleep duration with early
morning awakening. From a clinical perspective, varying
symptoms with regard to sleep and appetite have a decisive
influence on the choice of the individual treatment approach.
Although a substantial body of literature already describes
possible links between depression and body weight and/or
sleep/wake regulation (e.g., 11–13), a deeper understanding of
the connections between depression, obesity and sleep/wake
regulation is likely to have important implications for
individualized psychopharmacological and psychotherapeutic
treatment of comorbid obesity and depression.
Sleepiness is the main consequence of insufficient sleep and
dramatically influences the daytime brain arousal regulation.
Brain arousal regulation, in turn, plays an important role in order
to understand disturbed sleep/wake regulation in depression and
describes a key process required to stabilize vigilance for higher
cognitive performance. Vigilance as it is used here defines a tonic
neurophysiologic arousal level rather than a function of
attention. Besides, “arousal” has been defined as a relevant
dimension investigating mental illness by the Research Domain
Criteria project (14). Therefore, especially brain arousal
regulation has recently become an important focus of interest
in understanding the psychopathology of affective disorders.
The working group of Hegerl and colleagues defined the term
EEG-vigilance in order to examine brain arousal regulation by
means of electroencephalic activity (15). They found significantly
more stable EEG-vigilance regulation in depressed patients
compared to healthy controls and established the EEG-based
“vigilance regulation model for affective disorders” (16).
The model hypothesizes that depressed patients (DEP) show less
and later declines of brain arousal in resting state EEG recordings
than healthy controls (HC). Thus, depressed patients are assumed to
be characterized by a hyperstable EEG-vigilance regulation, whereas
manic patients are assumed to have an unstable brain arousal
regulation. Hegerl and colleagues (16, 17) characterize disturbed
brain arousal regulation as a pathophysiological factor for
depressive symptom complexes, such as sleep disturbances and
daytime sleepiness. Furthermore, their model provides
psychopathological explanations for, e.g., sensation avoidance and
withdrawal in depression as a consequence of an autoregulatory
attempt to handle hyperstable brain arousal.
In line with the predictions of the vigilance regulation model for
affective disorders, several studies that apply electroencephalography-April 2020 | Volume 11 | Article 200
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regulation in depressed patients (18–20). Regarding disturbed sleep/
wake regulation in depression, Hein and colleagues reported that
approximately half of depressed patients suffer from excessive
daytime sleepiness (EDS; 21) and that AD is a significant risk
factor of EDS in major depression.
Moreover, previous findings of Bixler et al. (22) support the
hypothesis that extreme daytime sleepiness (EDS) is more
strongly associated with affective disorders and obesity than
with sleep disordered breathing or sleep disruption per se. In a
polysomnographic study, Fernandez-Mendoza et al. (23) showed
that objective sleep disturbances predict incident daytime
sleepiness in depressed individuals, whereas an increase in
physiological sleep propensity predicts incident daytime
sleepiness in those without depression.
Interestingly, results of a study by Plante et al. (24) indicate
divergent associations between subjective and objective
sleepiness in depression. Thus, self-reported sleep duration and
EDS were positively associated with severity of depression,
whereas objective sleepiness parameters were negatively
associated with depressive symptoms.
Plante et al. (24) quantified objective sleepiness by the multiple
sleep latency test (MSLT), which usually takes about 7 h in the
course of a day and requires multiple devices. Although theMSLT is
the gold standard for measuring daytime sleepiness, its applicability
in a clinical setting is limited by its complex testing protocol.
Moreover, the MSLT only assesses sleep onset, but does not
provide information about the dynamics of brain arousal
regulation before sleep onset. Therefore, measurements of resting
state EEG activity constitute a preferable operationalization of
objective sleepiness.
Resting state EEG activity is recorded typically for 15–20 min
in eyes-closed condition and the dynamics of EEG-vigilance
levels are recorded over time. To standardize this measurement,
the working group of Hegerl and colleagues established an
automatic tool for the classification of brain arousal regulation
called VIGALL (Vigilance Algorithm Leipzig). VIGALL is an
EEG- and electrooculography (EOG)-based algorithm which
allows to objectively determine the level of EEG-vigilance and
its dynamics within EEG recordings (25). It automatically
classifies seven EEG-vigilance stages from wakefulness to
varying degrees of drowsiness to sleep onset in a 1s-resolution
(also see Table 1).AIMS AND HYPOTHESES
To date, there exists no VIGALL-based study investigating brain
arousal regulation in depressed patients with comorbid obesity,
although the literature clearly indicates that both diseases affect
sleep/wake regulation. Manifestations of sleep disturbances in
depressed patients are complex and so far, it remains unclear how
they are linked to obesity and subjective and objective sleepiness.
Moreover, based on the authors´ clinical expertise, obese
depressed patients may subjectively suffer more often from
severe daytime sleepiness and massive sleep disturbances thanFrontiers in Psychiatry | www.frontiersin.org 3normal-weighted depressed patients. Nevertheless, it is currently
unresolved whether such differences of subjective level of
suffering can also be detected in objective EEG-based brain
arousal regulation parameters or whether obese depressed
patients assess subjective sleepiness differently and may
overestimate the severity of disturbed sleep/wake regulation
compared to normal-weighted depressed patients.
To shed some light on the psychopathological manifestation
of disturbed sleep/wake regulation in depression and comorbid
obesity, the aim of the present study is to investigate the
relationship between subjective reported sleepiness and
objective measured sleepiness in depressed and obese patients.
Therefore, a sample of healthy controls (HC), obese patients
without depression (OB), depressed normal-weighted patients
(DEP), and patients with depression and obesity (OBDEP) were
examined via self-rating questionnaires and resting-state EEG
recordings applying VIGALL.
We compared subjective parameters of sleepiness (subjective
daytime sleepiness and subjective current states of sleepiness
before and after EEG recordings) with objective EEG-based
parameters of brain arousal regulation within and between
these four subgroups.
Taken together, we hypothesize that obesity and depression
affect the association between objective and subjective sleepiness.METHODS
Sample
As part of the OBDEP (Obesity and Depression) project
volunteers were consecutively recruited between February 2011
and November 2012 from the outpatient clinic of the Integrated
Research and Treatment Centre (IFB) for Adiposity Diseases
Leipzig, from the Department of Psychiatry and Psychotherapy
of the University Hospital Leipzig and via announcements
(intranet, internet, local newspapers). One aim of the OBDEP
project was to investigate the role of sleep and wakefulness
regulation in the relationship between obesity and depression.
The study was approved by University Leipzig Ethics Committee
(#015–10–18012009).
The recruiting process for potential participants aged 18–70




VIGALL Score EEG characteristics




Stage A A1 6 Predominant occipital a-activity
A2 5 High temporal and parietal a-activity
A3 4 Predominant frontal a-activity
Drowsiness Stage B B1 3 Low voltage EEG without a-activity
with horizontal SEM
B2/3 2 Increase of d- and q-power
Sleep onset Stage C 1 K-complexes and sleep spindlesApril 2020 | Volume 11 | Article 200
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severe psychiatric conditions, using the German version of the
checklist of the Structured Clinical Interview for DSM-IV (SKID;
26). Then, a full SCID-I was performed in cases of positive
SCID screening.
The following inclusion criteria were defined: free from (a)
psychiatric or neurological disorders other than depression, (b)
history of head injury with loss of consciousness exceeding 1 h, (c)
psychiatric medication, (d) acute or chronic infections, (e) current
medication with a recognized major impact on the immune system,
and (f) use of illegal drugs or abuse of alcohol within the past 6
months. After inclusion in the study, participants underwent a full
physical examination by a study physician with weight and height
measurements under standardized conditions.
The sample consists of N = 193 participants. We included
NHC = 66 healthy controls, NOB = 68 obese patients without
depression, NDEP = 16 depressed normal-weighted patients, and
NOBDEP = 43 patients with comorbid depression and obesity.
Subjective Sleepiness
We measured two subjective sleepiness parameters: daytime
sleepiness [see Day Time Sleepiness Via Epworth Sleepiness
Scale (ESS)] and situational sleepiness for a current state
immediately before and after EEG recordings (see Subjective
Situational Sleepiness Via Self-Rating Questionnaires: KSS,
SSS, VAS).
Day Time Sleepiness via Epworth Sleepiness
Scale (ESS)
The self-administered eight-item questionnaire “Epworth Sleepiness
Scale (ESS)” was applied as it is proposed as a simple method for
measuring subjective daytime sleepiness in adults (27) over the
course of an entire day. Patients rate how likely they are to fall asleep
in differing circumstances. Responders rate usual chances of dozing
off or falling asleep while engaged in eight different everyday
situations on 4-point scales with each item scored from 0 (not at
all) to 3 (very likely). The ESS score can range from 0 to 24, whereas
total scores of more than 10 points represent increasing levels of
excessive daytime sleepiness (EDS). Internal consistency
(Cronbach’s a: 0.73–0.86) of ESS is good, whereas external
validity (0.11–0.43), and test-retest reliability (0.73–0.82) is
described to be only weak to moderate (28).
Subjective Situational Sleepiness via Self-Rating
Questionnaires: KSS, SSS, VAS
In addition to the ESS, participants were asked to rate their self-
assessed current state of subjective sleepiness via the ordinal 1-
item questionnaires Stanford Sleepiness Scale (SSS, 29) and
Karolinska Sleepiness Scale (KSS; 30) before and after EEG
recordings as both of these scales are sensitive to short-
term fluctuations.
The KSS is a 10-point scale (1 = extremely alert to 10 = extremely
sleepy, falls asleep all the time) and was found to be highly
correlated to EEG and behavioral variables (30).
The SSS requires respondents to select one of seven (31)
statements on a 7-point scale (1 = feeling active, vital, alert or
wide awake to 7 = no longer fighting sleep, sleep onset soon, havingFrontiers in Psychiatry | www.frontiersin.org 4dream-like thoughts) best representing their level of perceived
current sleepiness. However, Akerstedt and colleagues (31, 32)
criticize that several of the seven statements actually refer to
fatigue or boredom rather than sleepiness.
As both SSS and KSS are applied in several recent studies for
assessing self-reported sleepiness, we used both questionnaires
for ordinal measurements of subjective sleepiness, although this
might be redundant.
Historically, sleepiness was assessed using visual analogue
scales (VAS, 33). Thus, we also used a VAS to evaluate the
individual sleepiness of each participant on a metric scale from 0
(= not at all) to 100 (= very much).
SSS, KSS, and VAS were assessed twice. Score differences
(DSSS, DKSS, DVAS) of measurements before (SSSpre/KSSpre/
VASpre) and after (SSSpost/KSSpost/VASpost) EEG recordings
were calculated.
After the EEG recordings, participants were further asked to
assess whether they had fallen asleep (variable ASLEEP) by
choosing one of the four options: 1 = I definitely fell asleep,
2 = I may have fallen asleep, 3 = I probably did not fall asleep, 4 =
I certainly did not fall asleep.
Covariates: Subjective Sleep Duration (SSD) and
Subjective Sleep Quality (SSQ)
To control for confounding effects on subjective and objective
sleepiness, we additionally assessed subjective sleep duration
(SSD) of the last night before EEG recordings and subjective
sleep quality (SSQ). SSQ is defined as the current degree of
relaxation after last night sleep. SSQ was determined using the
subscale “restedness” of a German sleep questionnaire SF-A
(“Schlaffragebogen A”; 34), which consists of 8 items.
Participants were asked to evaluate on a 5-point-scale (1 = not
at all, 5 = very much) to what extent adjectives describing the
sleep quality of the last night and well-being in the morning
applied to them. SSQ was calculated by the quotient [sum score
subscale “restedness”/8], where higher values correspond to
higher degree of feeling relaxed after night sleep.
Objective Sleepiness Parameter—EEG
Vigilance Regulation
EEG analyses are a well-established approach for assessing levels of
brain arousal and for monitoring sleep patterns. The EEG vigilance
concept we refer to in our study relates unspecific activation
patterns of the brain to a continuum from high alertness to
sleep onset.
Early on, Loomis et al. (35) classified different states of cerebral
activation on the basis of specific EEG patterns on a continuum
ranging from a concentrated waking state to a deep sleep state.
Bente (36) and Roth (37) further subdivided these EEG vigilance
levels depending on the frequency and topographic distribution of
the EEG waves (A1, A2, A3, B1, B2/3).
For an automatic classification of EEG vigilance, Hegerl and
colleagues developed the computer-based algorithm VIGALL
(Vigilance Algorithm Leipzig), which categorizes different EEG-
vigilance stages on the basis of the frequency and topographical
distribution of cerebral activity on a high temporal resolution. TheApril 2020 | Volume 11 | Article 200
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recordings of EEG and functional magnetic resonance imaging
(fMRI) data (38) and by including EEG-power source estimates
using sLORETA (standardized Low Resolution Brain
Electromagnetic Tomography). VIGALL classifies each second of
the EEG recording into one of seven EEG-vigilance stages ranging
from high alertness (stage “0”), to relaxed wakefulness (stages “A1”,
“A2”, “A3”), to drowsiness (stage “B1”, “B2/3”) up to sleep onset
(stage “C”). Table 1 defines EEG characteristics for each of these
EEG-vigilance stages.
EEGs were recorded in eyes-closed condition for 20 min. All
of the resting-state EEG recordings were taken between 08:00
and 18:00. They were recorded in a darkened and soundproofed
room where participants sat in a comfortable chair in an upright
position. The participants were instructed to keep their eyes
closed, to relax and not to try to resist the urge to fall asleep.
EEG setup and recording: To record the EEG, 31 electrodes
(sintered silver/silver chloride) with impedances below 10 kOhm
were attached according to the international 10–20 system. The data
were sampled at a rate of 1 kHz with a low-pass filter at 280 Hz,
using the common average as a reference measure. An
electrocardiogram (ECG) and an electrooculogram (EOG) were
also recorded to monitor cardiac and ocular artifacts. For EOG
recording, one electrode was placed on the forehead and a reference
electrode on the cheek below the eye. The ECG electrodes were
attached to the right and left wrist. The recordings were amplified
with a 40-channel QuickAmp device and post-processed with
BrainVision 2.0 software (BrainProducts, Gilching, Germany)
installed on aMicrosoftWindows XP-compatible computer system.
We then applied VIGALL to classify the EEG-vigilance stages
at a 1s-resolution for each participant. Artefacted segments were
excluded from further calculations based on established pre-
processing protocols.
For more detailed information about EEG data recording and
processing as well as operational methodology of VIGALL please
refer to Huang et al. (39) and the VIGALL 2.1 manual (25).
Several objective sleep/wake regulation parameters were
calculated on the basis of the VIGALL EEG-vigilance stages
(18, 39).
a. The proportion of time spent in each EEG-vigilance stage
over 20 min.
b. The mean vigilance values (MVV, range 1–7), i.e., averages of
EEG-vigilance scores over 20 min, based on assigning a
numeric value from 1 (lowest EEG-vigilance stage “C”) to 7
(highest EEG-vigilance stage “0”) to each EEG-vigilance
stage.
c. The criteria for the calculation of the arousal stability score
(ASS, range 1–11) are described in Table 2.
Obesity and Depression
Body mass index (BMI, [kg/m2]) was assessed according to
WHO guidelines (40, 41). To assess symptoms and severity of
depression, participants completed the revised Beck Depression
Inventory, 2nd edition (BDI-II; 42)
According to established cut-off values of BMI (40, 41) and
BDI-II scores (43) participants were classified as: (1) HC =Frontiers in Psychiatry | www.frontiersin.org 5healthy controls (BMI < 30, BDI-II score < 14), (2) OB =
obese non-depressed patients (BMI > 30, BDI-II score < 14),
(3) DEP = normal-weighted, depressed patients (BMI < 30, BDI-
II score > 13), and (4) OBDEP = obese depressed patients (BMI >
30, BDI-II score > 13).
Statistics
Statistical analyses were performed using R version 3.5.3 (44)
using packages cocor (45) and ordinal (46). Univariate between-
group differences of location for metric and ordinal variables (see
2.1) were assessed using Kruskal-Wallis tests.
To assess the existence of a global association between
subjective (SSSpre,KSSpre,VASpre, SSSpost,KSSpost,VASpost, DSSS,
DKSS, DVAS, ASLEEP) and objective (Proportions of VIGALL
Stages 0, A, B, C, MVV, ASS) measures of sleepiness, canonical
correlation analysis (CCA) between these two sets of variables
was performed. The null hypothesis of no association was tested
by means of the Pillai-Bartlett-Trace test (47), as implemented in
R package CCP (48). The reported p-value for this test was
computed based on a bootstrap approximation (9999
replications) of the null distribution to avoid unrealistic
Gaussianity assumptions.
Bivariate associations of subjective measures of sleepiness or
sleep quality and EEG vigilance-based measures (proportion of
EEG-vigilance stages, MVV, ASS) were quantified via Spearman
rank correlations and tested for significance as in Best and
Roberts (49). Inter-group differences of group-specific
estimated correlations were tested for significance based on
Diedenhofen and Musch (45).
vRegression analyses of measures of subjective situational (VAS,
KSS, ASS, sleep) or daytime sleepiness (ESS) were performed in
order to assess between-group heterogeneity of their associations
with objective EEG-vigilance based measures of situational
sleepiness (MVV, ASS). These analyses corrected for the effects of
age, gender, and sleep quality (SSQ) and included main effects as
well as interaction effects of depression, obesity, and either MVV or
ASS. The null hypothesis of homogeneity of association between
subjective and objective measures of sleepiness across the groups
defined by their (combined) depression and obesity status was
assessed by testing for the presence of significant interaction effects
between depression and/or obesity and the respective objective
measure (MVV/ASS) on the respective subjective sleepinessTABLE 2 | Criteria of the arousal stability score (ASS).
Score Stability level criterion Operational definition
11 less than 1/3 of all segments
not classified
as 0 or A/A1 stages
rigidity, only 0 and A1 stages
10 rigidity, only 0 and A stages
9 at least 1/3 of all segments
classified
as B stages
stage B emerged in minute 11–15
8 stage B emerged in minute 6–10
7 stage B emerged in 1–5
6 at least 1/3 of segments
classified
as B2/3 stages
stage B2/3 emerged in minute 11–15
5 stage B2/3 emerged in minute 6–10
4 stage B2/3 emerged in 1–5
3 occurrence of at least 1 C stage stage C emerged in minute 11–15
2 stage C emerged in minute 6–10
1 stage C emerged in 1–5April 2020 | Volume 11 | Article 200
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assumptions were validated using graphical regression model
diagnostics and the significance of interaction effects was assessed
by standard ANOVA F-tests. Proportional odds cumulative logit
models (cf. 50) were used for ordinal dependent variables (KSS, SSS,
ASLEEP) and the significance of interaction effects was assessed
using Chi-Square likelihood ratio tests. Reported p-values were not
corrected for multiple comparisons.RESULTS
Descriptive Statistics
Descriptive statistics for age, gender, SSD, SSQ, and subjective
sleep parameters for all four subgroups are presented in Tables
3A–C.
We included 132 female and 61 male participants in the
study. The mean age of all subjects was M = 37.6 years (SD = 12.4
years). Subgroups differed in age (p =.057) and in terms of
gender distribution (p =.016). Mean BDI-II scores were 4.4 (SD =
4.5) for HC, 5.4 (SD = 4.0) for OB, 24 (SD = 8.2) for DEP and 24Frontiers in Psychiatry | www.frontiersin.org 6(SD = 8.8) for OBDEP. Mean BMI was 24 (SD = 2.9) for HC, 43
(SD = 7.5) for OB, 24 (SD = 3) for DEP, and 45 (SD = 8.9)
for OBDEP.
Group differences were also found for SSQ (p =.005),
although SSD did not differ between subgroups (p =.44).
Subjective Sleepiness.
Subgroups differed significantly in several subjective sleepiness
parameters: self-reported daytime sleepiness (ESS, p =.010), self-
reported sleepiness before (VASpre, p =.004; KSSpre, p =.003; SSSpre,
p < .001), and after EEG recordings (SSSpost, p =.007) as well as in
KSS score differences post and pre EEG (DKSS, p =.004), but did not
differ in reported likelihood of having fallen asleep.
Moreover, we calculated correlations between subjective
daytime sleepiness and subjective situational sleepiness.
Overall, Spearman rank correlations were significantly positive
between ESS – and SSSpre (r =.26, p < .001), KSSpre (r =.33, p <
.001), VASpre (r =.25, p < .001), SSSpost (r =.19, p =.008), and
KSSpost (r =.27, p < .001). Score differences after and before EEG
recordings (DSSS/KSS/VAS) did not correlate significantly
with ESS.TABLE 3A | Descriptive statistics (metric variables).
HC (N=66) OB (N=68) DEP (N=16) OBDEP (N=43)
Mean SD Mean SD Mean SD Mean SD p (Kruskal-Wallis)
Age 34 12 39 12 38 13 41 13 0.057
VAS (pre-EEG) 29 25 34 27 39 29 47 25 0.0039
VAS (post-EEG) 32 24 33 27 39 26 41 30 0.41
D VAS (post - pre) 3.3 26 -0.96 31 -0.31 37 -5.8 27 0.56
D KSS (post - pre) 0.52 1.4 -0.21 1.6 0 1.7 -0.4 1.7 0.0035
D SSS (post - pre) 0.21 1 -0.088 1.2 -0.19 1 -0.14 0.97 0.22
SSD (minutes) 432 69 427 81 462 74 436 75 0.44
SSQ 3.3 0.65 3.3 0.68 2.9 0.67 3 0.82 0.005
ESS 7.7 3.1 8.1 3.9 8.4 3.5 9.8 3.3 0.01April 2020 | VoluTABLE 3C | Descriptive statistics (ordinal variables).
HC (N=66) OB (N=68) DEP (N=16) OBDEP (N=43)
Median IQR Median IQR Median IQR Median IQR p (Kruskal-Wallis)
KSS (pre-EEG) 3 3 – 4 3 3 – 5 4.5 3 – 6 5 3 – 6 0.0027
KSS (post-EEG) 4 3 – 5 3 2 – 4 4 3 – 5 4 3 – 6 0.12
SSS (pre-EEG) 2 2 – 2 2 1 – 3 3 2 – 4 3 2 – 4 9.4e-05
SSS (post-EEG) 2 2 – 3 2 2 – 3 3 2 – 3 2 2 – 4 0.0073TABLE 3B | Descriptive statistics (categorical variables).
HC (N=66) OB (N=68) DEP (N=16) OBDEP (N=43)
N % N % N % N % p (c2)
Gender female 40 60.6 54 79.4 7 43.8 31 72.1 0.02
male 26 39.4 14 20.6 9 56.2 12 27.9
ASLEEP definitively 9 13.6 5 7.4 1 6.2 9 20.9 0.11
possibly 14 21.2 18 26.5 4 25 6 14
probably not 9 13.6 17 25 0 0 9 20.9
surely not 34 51.5 28 41.2 11 68.8 19 44.2me 11 | Article 200
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daytime/situational sleepiness and the covariate subjective sleep
quality (SSQ). Overall, Spearman rank correlations were
significantly negative between SSQ - and SSSpre (r = −.44, p <
.001), KSSpre (r = −.45, p < .001), VASpre (r = −.42, p < .001),
SSSpost (r = −.35, p < .001), KSSpost (r = −.34, p < .001), and
VASpost (r = −.29, p < .001). Score differences pre and post EEG
recordings (DSSS/KSS/VAS) did not correlate significantly with
SSQ. Furthermore, Spearman rank correlations between SSQ and
ESS were significantly negative (r = −.28, p < .001).
Objective Sleepiness
Subgroups did not differ significantly in objective sleepiness
parameters. Specifically, normal-weighted depressed and obese
depressed patients did not differ significantly in objective
sleepiness parameters according to results of the Wilcoxon
rank sum test (MVV: p = 0.39; ASS: p = 0.7). Detailed
information on distributions of EEG-vigilance stages, MVV
and ASS are presented in Table 3D.
Inference Statistics
Correlations Between Objective and Subjective
Sleepiness Parameters
Canonical correlation analysis results indicate the existence of
highly significant global association between subjective (SSSpre,
KSSpre,VASpre, SSSpost,KSSpost,VASpost, DSSS, DKSS, DVAS,
ASLEEP) and objective (Proportions of VIGALL Stages 0, A,
B, C, MVV, ASS) measures of sleepiness (Pillai-Bartlett-Trace
test, p = 0.001). For ease of interpretation, we report the relevant
bivariate objective-subjective correlations in the following.
Proportion of EEG Vigilance Stages
Correlations between the proportions of time spent in EEG-
vigilance stages “0,” “A,” “B,” and “C,” respectively, and
subjective sleepiness parameters were calculated.
Over all subjects, correlations revealed significant
associations of the proportion of time spent in EEG-vigilance
stages “A,” “B,” and “C” with the reported likelihood of having
fallen asleep (“A”: r =.22, p =.002; “B”: r = −.31, p < .001; “C”:
r = −.34, p < .001) and ESS (“A”: r = −.15, p =.04; “B”: r =.15,
p =.035; “C”: r =.16, p =.026). In addition, proportion of time
spent in stages “A” or “C” was associated (marginally)
significantly with SSSpre (“A”: −.14, p =.052; “C”:.18, p =
0.014). Furthermore, proportion of time spent in EEG-
vigilance stage “A” was associated with pre-post changes inFrontiers in Psychiatry | www.frontiersin.org 7SSS (r =.15, p =.037) and proportion of time spent in EEG-
vigilance stage “C” was associated significantly with both
KSSpre (r =.22, p =.002) and KSSpost (r =.2, p =.0062). None
of the subjective sleepiness parameters were correlated
significantly with proportion of time spent in EEG-vigilance
stage “0.”
Correlations between EEG-vigilance stage proportions and
subjective sleepiness parameters did not differ significantly
between DEP and OBDEP. Significant correlation differences
were found between DEP and HC for the correlations of time
spent in EEG-vigilance stage “0” with pre-post changes in KSS
(corr. difference:.55, p = 0.05), for the correlations of time spent
in “A” with VASpost (corr. difference: −.56, p = 0.05) and for the
correlations of time spent in “B” with VASpre (corr.
difference:.63, p =.02), VASpost (corr. difference:.69, p =.01),
and SSQ (corr. difference: −.61, p =.03). Significant correlation
differences were found between OB and OBDEP for the
correlations of time spent in stage B with KSSpre (corr.
difference: −.41, p =.03) and for the correlations of time spent
in stage C with VASpost (corr. difference:.46, p =.02) and pre-post
changes in VAS (corr. difference:.48, p =.01).
MVV
Over all subjects, correlations revealed significant associations
between MVV and the reported likelihood of having fallen asleep
(r =.37, p < .001), MVV, and ESS (r = −.14, p =.05), and marginally
significant associations betweenMVV and KSSpre (r = −.13, p =.07).
Correlations between MVV and VASpre (correlation
difference = −.66, p =.01) as well as between MVV and SSQ
(correlation difference =.69, p =.01) differed significantly
between HC and DEP. Correlations between objective and
subjective sleepiness parameters did not differ significantly
between DEP and OBDEP or between OB and OBDEP.
ASS
Over all subjects a significant correlation was found between ASS
and the reported likelihood of having fallen asleep (r = −.37,
p < .001).
Comparing HC and DEP, correlations between ASS and VASpre
differed significantly (correlation difference =.60, p =.03), whereas
correlations between ASS and SSQ (correlation difference = −.54,
p =.06) differed marginally. Moreover, correlations between ASS
and KSSpre (r = −.38, p =.04) differed significantly between OB
and OBDEP. No statistically significant correlation differences
were found between DEP and OBDEP.TABLE 3D | Distributions of EEG-vigilance stages, mean vigilance value (MVV), and arousal stability score (ASS).
HC (N=66) OB (N=68) DEP (N=16) OBDEP (N=43)
Mean SD Mean SD Mean SD Mean SD p (Kruskal-Wallis)
Proportion Stage 0 0.07 0.12 0.088 0.12 0.12 0.19 0.12 0.18 0.62
Proportion Stage A 0.47 0.3 0.48 0.33 0.54 0.31 0.47 0.32 0.85
Proportion Stage B 0.43 0.29 0.4 0.3 0.3 0.3 0.39 0.28 0.37
Proportion Stage C 0.012 0.044 0.012 0.048 0.012 0.033 0.0077 0.03 0.66
MVV 3.5 0.99 3.6 0.98 4 1.1 3.7 0.96 0.25
ASS 3.9 2.2 3.7 1.9 3.2 1.9 3.3 1.5 0.52April 2020 | Volume 11 | Article 200
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parameters for each subgroup are presented in Table 4.
ANOVAs
MVV/ASS and Subjective Situational Sleepiness (SSS; KSS,
VAS)
Main Effects “age”. Regression analyses with either MVV or ASS
as independent variables showed significant main effects of age on
VASpost, DSSS, DKSS and DVAS (MVV: DVAS: F = 5.99, p =.015;
DKSS: F = 12.80, p < .001;DSSS: F = 7.99, p < .001; VASpost: F = 16.60,
p < .001; ASS: DVAS: F = 5.71, p =.018; DKSS: F = 13.30, p < .001;
DSSS: F = 7.91, p =.006; VASpost: F = 16.10, p < .001). Moreover,
regression analyses of MVV as independent variable revealed a sig-
nificant main effect of age on KSSpost(F = 4.99, p =.026), whereas
regression analyses of ASS as dependent variable revealed a significant
main effect of age on SSSpost(F = 3.91, p =.048).
Main effect “SSQ”. Regression analyses with either MVV
(DVAS: F = 4.50, p =.035; KSSpre: F = 5.92, p =.015; VASpre: F =
39.80, p < .001; SSSpre: F = 40.90, p < .001; SSSpost: F = 22.60, p <
.001; VASpost: F = 13.80, p < .001; KSSpost: F = 23.60, p < .001) or
ASS (DVAS: F = 4.29, p =.040; KSSpre: F = 5.31, p =.022; VASpre:
F = 39.80, p < .001; SSSpre: F = 42.40, p < .001; SSSpost: F = 24.10,
p < .001; VASpost: F = 13.40, p < .001; KSSpost: F = 23.50, p < .001)
as independent variables revealed significant main effects of SSQ
on almost all parameters of subjective situational sleepiness
except DSSS and DKSS.
Main effect “gender”. Regression analyses with either MVV or ASS
as independent variables revealed significant main effects of gender on
DVAS (MVV: F = 4.92, p =.028, ASS: F = 4.69, p =.032) and KSSpre
(MVV: F = 5.92, p =.015, ASS: F = 6.19, p =.013) Regression analysesFrontiers in Psychiatry | www.frontiersin.org 8with MVV as independent variable further revealed a significant main
effect of gender on DKSS (F = 4.92, p =.028).
Main effect “depression”. Regression analyses with either MVV
(VASpre: F = 6.49, p =.012; VASpost: F = 4.14, p =.043, KSSpre: F =
5.96, p =.015, SSSpre: F = 11.90, p < .001, SSSpost: F =7.17, p =.007)
or ASS (VASpre: F = 5.31, p =.022; VASpost: F = 4.14, p =.043,
KSSpre: F = 6.20, p =.013, SSSpre: F = 11.60, p < .001, SSSpost: F =
7.74, p =.005) as independent variables revealed a significant
main effect of depression on almost all parameters of subjective
situational sleepiness pre and post EEG recordings, except
KSSpost, but not on score differences of subjective sleepiness
(DSSS, DKSS, DVAS).
Main effect “obesity”. Main effects of obesity on VASpre were found
to be significant (MVV: F = 3.76, p =.054; ASS: F = 3.85, p =.051).
Regression analyses of MVV as dependent variable revealed a signifi-
cant main effect of obesity on DKSS (F = 4.09, p =.045). Furthermore, a
significant main effect of obesity (F = 3.73, p =.053) on ASLEEP was
found.
Associations between subjective and objective sleepiness
parameters. Moreover, regression analyses revealed a signifi-
cant association between MVV and ASLEEP (F = 23.40, p < .001)
as well as between ASS and ASLEEP (F = 27.90, p < .001).
Interaction Effects. Regression analyses revealed a marginally
significant interaction effect of depression on the association of
MVV with VASpre (F = 3.73, p =.055).
Moreover, results showed a significant interaction effect of
obesity on the association between of ASS with VASpre (F = 2.79,
p =.042).
MVV/ASS and Subjective Daytime Sleepiness
Main Effects “SSQ”. Main effects of SSQ on ESS (F= 15.30, p
< .001) were found to be significant.
Main effect “depression”. Regression analyses with MVV as
independent variable revealed a significant main effect of
depression on ESS (F = 4.84, p =.029).
Associations between subjective and objective sleepiness parameters.
Moreover, regression analyses revealed a marginally significant
association between MVV and ESS (F = 3.68, p =.057).
Interaction Effects. Regression analyses revealed no interaction
effects on the association between objective sleepiness and sub-
jective daytime sleepiness.DISCUSSION
In the present study, we investigated the relationship between
obesity, depression, subjective reported sleepiness, and objective
measured sleepiness.
To investigate this, we examined reported daytime and
situational sleepiness as well as objectively measured EEG-based
sleepiness parameters in normal-weighted depressed, obese
depressed, obese non-depressed patients, and healthy controls.
Generally speaking, subjective sleepiness parameters differed
significantly between the four subgroups, whereas objectiveTABLE 4 | Correlation between EEG-based and subjective sleepiness, per
subgroup.
EEG-Based Subjective HC OB DEP OBDEP
MVV SSS (pre-EEG) −0.062 0.112 0.297 0.195
KSS (pre-EEG) 0.040 0.058 0.230 0.435
VAS (pre-EEG) −0.103 0.029 0.498 0.160
SSS (post-EEG) −0.017 −0.079 0.450 −0.005
KSS (post-EEG) 0.067 −0.009 0.276 0.213
VAS (post-EEG) −0.125 0.059 0.352 0.043
D SSS (post - pre) 0.027 −0.206 0.135 −0.256
D KSS (post - pre) 0.080 −0.042 0.115 −0.254
D VAS (post - pre) −0.029 −0.048 −0.173 −0.060
ASLEEP −0.301 −0.512 −0.517 −0.257
ESS 0.034 0.127 0.322 0.148
SSQ 0.099 −0.107 −0.438 −0.107
ASS SSS (pre-EEG) −0.062 0.112 0.297 0.195
KSS (pre-EEG) 0.040 0.058 0.230 0.435
VAS (pre-EEG) −0.103 0.029 0.498 0.160
SSS (post-EEG) −0.017 −0.079 0.450 −0.005
KSS (post-EEG) 0.067 −0.009 0.276 0.213
VAS (post-EEG) −0.125 0.059 0.352 0.043
D SSS (post - pre) 0.027 −0.206 0.135 −0.256
D KSS (post - pre) 0.080 −0.042 0.115 −0.254
D VAS (post - pre) −0.029 −0.048 −0.173 −0.060
ASLEEP −0.301 −0.512 −0.517 −0.257
ESS 0.034 0.127 0.322 0.148
SSQ 0.099 −0.107 −0.438 −0.107April 2020 | Volume 11 | Article 200
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previously been reported by Denton et al. (51), who reported
weak correlation only between subjective but not objective
sleepiness and affective disorders and also by Plante et al. (24,
52) who reported divergent associations between subjective and
objective measures of hypersomnolence and depression. In
addition, the fact that “[…] only objective but not subjective
sleepiness was significantly associated with the reported
likelihood of having fallen asleep during EEG recordings […
could suggest that some] patients may have rated depression
related tiredness or apathy as sleepiness,” as one reviewer put it.
Descriptive analyses showed that both subjective daytime
sleepiness and subjective sleep quality were associated with
reported situational sleepiness. However, directions and
magnitudes of changes in reported sleepiness before and after
EEG recordings did not vary systematically with subjective
daytime sleepiness or with subjective sleep quality.
Counterintuitively, 20 min of resting in eyes-closed condition
seem to change reported situational sleepiness pre and post EEG
recordings in the same way regardless of subjective daytime
sleepiness or reported sleep quality.
Furthermore, ANOVA results provide evidence that both
depression and obesity are associated with subjective sleepiness.
While depression significantly affects both subjective daytime
sleepiness, i.e., ESS, and almost all parameters of reported
situational sleepiness pre and post EEG recordings, obesity
does not seem to be associated with subjective daytime
sleepiness and only with reported situational sleepiness before
EEG recordings when evaluated using the metric visual
analogue scale.
These findings partly contradict the results of previous studies
exploring the role of obesity in excessive daytime sleepiness.
Thus, a study by Slater and colleagues (53) identified obesity as
an independent predictor for subjective daytime sleepiness.
Similarly, Maugeri and colleagues (54) investigated a non-
depressed cohort and found short sleep duration and EDS to
be associated with greater odds of overweight and obesity,
independent of diet and physical activity.
Moreover, ANOVA results show that both depression and
obesity affect the association between objective measured
sleepiness and subjective reported sleepiness before EEG
recordings when assessed by the metric visual analogue scale,
but not when assessed by KSS or by SSS.
To summarize: In the present study, reported situational
sleepiness before EEG recordings was associated with obesity
only when the former was assessed by the metric VAS. Similarly,
depression and obesity were found to affect the association
between objective measured sleepiness and subjected reported
sleepiness before EEG recordings only when the latter was
assessed by the metric VAS. We now discuss two possible
explanations for this surprising result, which may also be
related to methodological shortcomings of our study.
As participants were asked to evaluate their situational
sleepiness simultaneously on a metric scale (VAS) displayed as
a horizontal line with a range from 0 to 100 on which the
participants mark how tired they are, and on two ordinal scaleFrontiers in Psychiatry | www.frontiersin.org 9(KSS and SSS), this triple query may distort the recorded
responses. KSS and SSS are very similar questionnaires
requiring responders to select one of 10 (KSS) or 7 (SSS)
statements about their situational sleepiness. Responding to
KSS and SSS shortly after one another may cause cognitive
dissonance avoidance behavior among the participants, in the
sense that they may compare their answers to KSS and SSS in
order to choose maximally consistent statements.
Therefore, KSS and SSS scores could be biased by a kind of
social desirability bias, as participants may try to give reliable and
valid answers. In contrast, VAS scoring might be more intuitive
and easier to choose compared to KSS and SSS, where
participants carefully weigh up, and potentially attempt to
compare, the 7 or 10 statements that differ only slightly from
each other.
Additionally, and more generally, another methodological
drawback of our study is due to the fact that different concepts
of sleepiness, fatigue and exertion coexist and might be cross-
associated (55). Therefore, it is questionable whether both SSS
and KSS are suitable for validly measuring situational sleepiness.
To our knowledge, no studies exist that compare the reliability
and validity of SSS and KSS to assess situational sleepiness.
Taken together, the VAS is likely to provide more reliable and
valid measurements to evaluate situational sleepiness.
Further results show that objective measured sleepiness was
significantly associated with the reported likelihood of having
fallen asleep during EEG recordings and was almost significantly
associated with subjective daytime sleepiness. These results are in
line with recent findings of a study by Jawinski et al. (56), which
investigated the association between recorded and reported
sleepiness in a population-based cohort study including 10,000
randomly selected inhabitants of Leipzig, Germany. They found
moderate correlations between objective sleepiness parameters
and the reported likelihood of having fallen asleep.
Although analyses revealed no significant correlation
differences of objective and subjective sleepiness parameters
between normal-weighted depressed (DEP) and obese
depressed patients (OBDEP), we can report, nevertheless, that
correlations in the OBDEP subgroup were systematically weaker
than in the DEP subgroup (see Table 4).
Interestingly, while normal-weighted depressed patients (DEP)
and healthy controls (HC) differ significantly with regard to the
strengths and directions of correlations between some subjective
sleepiness parameters and the objective sleepiness parameter
MVV, our results show that strengths and directions of
correlations between objective and subjective sleepiness
parameters are very similar in the obese non-depressed (OB)
and obese depressed subgroup (OBDEP). Thus, in the normal-
weighted subgroup, this study provides some evidence that
depression affects the association between subjective and
objective sleepiness, but not in the obese subgroup.
This pattern is much less clear for correlations between the
objective sleepiness parameter ASS and subjective sleepiness
parameters. Indeed, this might be due to the fact that ASS is
designed to measure dynamic aspects of brain arousal regulation
and not just mean situational sleepiness over a 20-min time span.April 2020 | Volume 11 | Article 200
Minkwitz et al. Sleepiness in Obesity and DepressionTherefore, the functional course of changing EEG-vigilance over 20
min captured by ASS may conceptually define a different construct
than situational sleepiness itself at a certain measure time before
and after EEG recordings, as these constructs are based on different
temporary conditions and may describe not just current states, but
also traits of long term individual characteristics.
Thus, MVV is likely to be a valid measurement for objective
situational sleepiness, whereas ASS may be better suited to
describe brain arousal regulation according to the vigilance
regulation model for affective disorders. Accordingly, we
conclude that brain arousal regulation and consequently
objective sleepiness might be more complex in depressed
patients, especially with comorbid obesity, and should
therefore be examined again more closely by means of more
precise statistical methods. In line with such potentially complex
associations of sleep/wake regulation with depression, a study by
Geoffrey and colleagues (57) analyzing a nationally
representative survey of the US adult population showed that
insomnia sleep patterns and hypersomnia often co-occur in
depressed patients. As our results show, controlling for
additional covariates such as obesity may help to provide
further insight into such phenomena in the depressed cohort.
In a similar vein, further studies should also assess more detailed
clinical characteristics of depressive symptoms to distinguish
between depression and depression with atypical features in
order to improve our understanding of these associations.
However, the small sample size, especially of the normal-
weighted depressed subgroup is a drawback, which complicates
the interpretation of the findings.
Furthermore, the present study and previous studies on brain
arousal regulation using VIGALL only analyzed minute-wise
pseudo-means of the ordinal high-frequency EEG-vigilance
stages and fairly ad-hoc summaries of their evolution over
time, which may obscure the complexity of brain arousal
regulation dynamics. Taken together, for more precise analyses
of both objective sleepiness and brain arousal regulation
dynamics in depressed patients and their association with or
confounding by comorbidities like obesity, future studies should
take functional dynamics of the EEG-vigilance stages over the
whole recording period in the original 1s-resolution into account
in order to avoid the loss of information incurred by simply
averaging EEG-segments over time (MVV) or merely analyzing
first-occurrence times of lower EEG-vigilance stages and coarse
categorizations of vigilance stage distributions over time (ASS).CONCLUSION
This study provides some evidence that both depression and
obesity may affect the association between objective and
subjective sleepiness.
If confirmed, this insight might have future implications for
individualized diagnosis and treatment approaches in comorbid
depression and obesity. For example, depressive syndromes
related to sleep/wake regulation may affect treatment decisions
with regard to different substance classes of antidepressants thatFrontiers in Psychiatry | www.frontiersin.org 10take into account their sleep-inducing effects and/or their effects
on patients´ activity levels.
This clinical decision should also consider that the subjective
assessment of sleep/wake regulation may be affected by obesity,
as the present study indicates. To achieve optimal treatment
choices, then, it might be beneficial to rely on more objective
measures based on the resting state EEG recordings, which are
broadly available in a clinical setting and increasingly part of the
standard set of diagnostics for depressed patients. Such VIGALL-
based diagnostics are a more economic and time-efficient choice
that is easier to perform in clinical settings than the MSLT.DATA AVAILABILITY STATEMENT
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